Arkolith/Insider Trading/MNPR/Form 4

Robinson Chandler

Chief Executive Officer, DirectorMonopar Therapeutics (MNPR) · full profile →Form 4 · filed Dec 8, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
0 non-derivative · 2 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 2, 2025Grant(A)17K—$017K
Dec 2, 2025Grant(A)49K—$0122K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001437749-25-037163) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML